Term
|
Definition
|
|
Term
|
Definition
|
|
Term
|
Definition
|
|
Term
|
Definition
| sotalol, amiodarone, ibutilide |
|
|
Term
|
Definition
|
|
Term
|
Definition
|
|
Term
|
Definition
|
|
Term
|
Definition
| disopyramide, quinidine, procainamide |
|
|
Term
|
Definition
|
|
Term
|
Definition
|
|
Term
|
Definition
|
|
Term
|
Definition
|
|
Term
|
Definition
|
|
Term
|
Definition
|
|
Term
|
Definition
|
|
Term
|
Definition
|
|
Term
| elimination by kidney only (3) |
|
Definition
| sotalol, propafenone, disopyramide |
|
|
Term
| indicated for atrial and ventricular arrhythmias in CHF |
|
Definition
|
|
Term
| used for cardioconversion |
|
Definition
|
|
Term
|
Definition
|
|
Term
|
Definition
|
|
Term
|
Definition
| fast acetylators: torsades; slow acetylators: agranulocytosis, SLE |
|
|
Term
| how does lidocaine affect SA and AV nodes? |
|
Definition
|
|
Term
| vfib associated with acute MI; tx? |
|
Definition
|
|
Term
|
Definition
| CNS toxicity, slurred speech, numbness, fasciculations |
|
|
Term
|
Definition
| propafenone, lidocaine, diltiazem, verapamil |
|
|
Term
| indicated for atrial flutter and afib |
|
Definition
| propafenone, ibutilide; disopyramide, quinidine, flecainide |
|
|
Term
| contraindicated in structural heart disease |
|
Definition
|
|
Term
| indicated for hyperthyroidism-related afib, SVT |
|
Definition
|
|
Term
| tx for sinus brady or AV dissociation |
|
Definition
|
|
Term
|
Definition
|
|
Term
| liver metabolite of procainamide |
|
Definition
|
|
Term
| can be used for both atrial and ventricular arrhythmias |
|
Definition
| sotalol, propanolol, amiodarone |
|
|
Term
| tx for AV nodal reentrant SVT |
|
Definition
| AV node blockers: Ca channel blockers, beta blockers, digoxin, adenosine |
|
|
Term
|
Definition
| class IV: verapamil, dilitiazem |
|
|
Term
|
Definition
| class I: procainamide, quinidine, disopyramide, lidocaine, propafenone, flecainide |
|
|
Term
|
Definition
| class III: sotalol, amiodarone, ibutilide, dofetilide, dronedarone |
|
|
Term
| mechanism that causes torsades? |
|
Definition
|
|
Term
| mechanism that causes PVD? |
|
Definition
|
|
Term
| EAD occurs during phase __; DAD occurs during phase __ |
|
Definition
|
|
Term
| EAD is mediated by __ channels; DAD is mediated by __ channels. |
|
Definition
| EAD-K channels; DAD-Ca channels |
|
|
Term
|
Definition
| hypoxemia, acidosis, hypokalemia, class III and class IA antiarrhythmics, bradycardia, F>M |
|
|
Term
|
Definition
| tachycardia, hypokalemia, hypercalcemia, digoxin |
|
|
